The Royal Brompton Cystic Fibrosis (CF) Clinical Trials team celebrated three well-deserved wins at the North West London Clinical Research Awards, where they were recognised for their outstanding work carrying out ground-breaking CF research.
Wednesday was a vital day at the start of an important month in our fight to make sure people with cystic fibrosis can get their hands on life-changing new treatments. Here Trust Chief Executive David Ramsden shares his experience and looks ahead to the Parliamentary debate.
He’s defied Dragons and all the odds to launch a world-famous luggage brand, and now as Rob Law MBE unveils his new autobiography, the entrepreneur talks to us about some of the lessons he has learned from a life balancing cystic fibrosis (CF), the ever-changing business world and raising a family.
Intrepid Chris Sparrow is running six marathons in six days through the desert dressed as a Star Wars storm trooper to raise money for the Cystic Fibrosis Trust, and jokingly tells anyone who doubts he’ll go the distance: “I find your lack of faith disturbing.” What made him decide to take on this insane challenge? Read on to find out!
With genetic tracking in the news as researchers seek to understand more about COVID-19, we wanted to share how researchers funded by the Trust are using it to both improve treatments for CF infections and help reduce cross-infection between people living with cystic fibrosis.
With over 2,000 known mutations of the cystic fibrosis (CF) gene, CF affects everyone with the condition differently. At the Cystic Fibrosis Trust we’re committed to finding the most effective ways of treating everyone with CF, including those who won’t benefit from the ‘CFTR modulators’ currently available. Find out what progress has been made so far.
